Augmented production of chemokines (monocyte chemotactic protein-1 (MCP- 1), macrophage inflammatory protein-1α (MIP-1α) and MIP-1β) in patients with systemic sclerosis: MCP-1 and MIP-1α may be involved in the development of pulmonary fibrosis

Clinical and Experimental Immunology

Volumn 117, Issue 1, 1999, Pages 159-165

  Hasegawa, M ^a   Sato, Shinichi ^a   Takehara, K ^a  

^a KANAZAWA UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

Chemokine; Pulmonary fibrosis; Skin sclerosis; Systemic sclerosis

Indexed keywords

CHEMOKINE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOGENESIS; IMMUNOREGULATION; LUNG FIBROSIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; SYSTEMIC SCLEROSIS;

ADULT; AGE OF ONSET; AUTOIMMUNE DISEASES; CHEMOKINE CCL2; CHEMOTAXIS, LEUKOCYTE; ENDOTHELIUM; EPIDERMIS; FEMALE; HUMANS; MACROPHAGE INFLAMMATORY PROTEIN-1; MALE; MIDDLE AGED; MONOCYTES; PULMONARY FIBROSIS; SCLERODERMA, SYSTEMIC; SKIN;

EID: 0032974438     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1999.00929.x     Document Type: Article

References (26)

1. LeRoy EC, Smith EA, Kahaleh MB, Trojanowska M, Silver RM. A strategy for determining the pathogenesis of systemic sclerosis: Is transforming growth factor β the answer? Arthritis Rheum 1989; 32:817-25.
2. Roumm AD, Whiteside TL, Medsger TAJ, Rodnan GP. Lymphocytes in the skin of patients with progressive systemic sclerosis: Quantification, subtyping and clinical correlations. Arthritis Rheum 1984; 27:645-53.
3. White B. Immunopathogenesis of systemic sclerosis. Rheum Dis Clin N Am 1996; 22:695-708.
4. Rossi GA, Bitterman PB, Rennard SI, Ferrans VJ, Crystal RG. Evidence for chronic inflammation as a component of the interstitial lung disease associated with progressive systemic sclerosis. Am Rev Resp Dis 1985; 131:612-7.
5. Yoshimura T, Yuhki NKMS, Appella E, Lerman MI, Leonard EJ. Human monocyte chemoattractant protien-1 (MCP-1): Full-length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Letters 1989; 244:487-93.
6. Leonard EJ, Yoshimura T. Human monocyte chemoattractant protein- 1 (MCP-1). Immunol Today 1990; 11:97-101.
7. Jiang Y, Beller DI, Frendl G, Graves DT. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production human monocytes. J Immunol 1992; 148:2423-8.
8. Koch AE, Kunkel SL, Harlow LA et al. Enhanced production of monocyte chemoattractant protein-1 in rheumatoid arthritis. J Clin Invest 1992; 90:772-9.
9. Antoniades HN, Neville-Golden J, Galanopoulos T, Kradin RL, Valente AJ, Graves DT. Expression of monocyte chemoattractant protein 1 mRNA in human idiopathic pulmonary fibrosis. Proc Natl Acad Sci USA 1992; 89:5371-5.
10. Stahl RAK, Thaiss F, Disser M, Helmchen U, Hora K, Schlondorff D. Increased expression of monocyte chemoattractant protein-1 in anti-thymocyte antibody-induced glomerulonephritis. Kidney Int 1993; 44:1036-47.
11. Fahey III TJ, Tracey KJ, Tekamp-Olson P, Cousens LS, Jones WG, Shires GT, Cerami A, Sherry B. Macrophage inflammatory protein 1 modulates macrophage function. J Immunol 1992; 148:2764-9.
12. Koch AE, Kunkel SL, Harlow LA, Mazarakis DD, Haines GK, Burdick MD, Pope RM, Strieter RM. Macrophage inflammatory protein-1α: A novel chemotactic cytokine for macrophages in rheumatoid arthritis. J Clin Invest 1994; 93:921-8.
13. Standiford TJ, Rolfe MW, Kunkel SL et al. Macrophage inflammatory protein-1α expression in interstitial lung disease. J Immunol 1993; 151:2852-63.
14. Subcommittee for Scleroderma Criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Arthritis Rheum 1980; 23:581-90.
15. LeRoy EC, Black C, Fleischmajer R, Jablonska S, Krieg T, Medsger TA Jr, Rowell N, Wollheim F. Scleroderma (systemic sclerosis): Classification, subsets and pathogenesis. J Rheumatol 1988; 15:202-5.
16. Sato S, Ihn H, Kikuchi K, Takehara K. Antihistone antibodies in systemic sclerosis: Association with pulmonary fibrosis. Arthritis Rheum 1994; 37:391-4.
17. Taub DD, Conlon K, Lloyd AR, Oppenheim JJ, Kelvin DJ. Preferential migration of activated CD4+ and CD8+ T cells in response to MIP-1α and MTP-1β. Science 1993; 260:355-8.
18. Tanaka Y, Adams DH, Huscher S, Hirano H, Siebenlist U, Stephen S. T cell adhesion induced by proteoglycan-immobilized cytokine MTP-1β. Nature 1993; 361:79-82.
19. Silver RM, Miller KS, Kinsella MB, Smith EA, Schabel SI. Evaluation and management of scleroderma lung disease using bronchoalveolar lavage. Am J Med 1990; 88:470-6.
20. Bolster MB, Ludwicka A, Sutherland SE, Strange C, Silver RM. Cytokine concentration in bronchoalveolar lavage fluid of patients with systemic sclerosis. Arthritis Rheum 1997; 40:743-51.
21. Kehrl JH, Wakefield LM, Roberts AB, Jakowlew S, Alvarez-Mon M, Derynck R, Sporn MB, Fauci AS. Production of transforming growth factor β by human T lymphocytes and its potential role in the regulation of T cell growth. J Exp Med 1986; 163:1037-50.
22. Assoian RK, Fleurdelys BE, Stevenson HC, Miller PJ, Madtes DK, Raines EW, Ross R, Sporn MB. Expression and secretion of type β transforming growth factor by activated human macrophages. Proc Natl Acad Sci USA 1987; 84:6020-4.
23. Gruschwitz M, Muller P, Sepp N, Hofer E, Fontana A, Wick G. Transcription and expression of transforming growth factor type β in the skin of progressive systemic sclerosis: A mediator of fibrosis? J Invest Dermatol 1990; 94:197-203.
24. De Gabrielli A, Loreto C, Taborro R et al. Immunohistochemical localization of intracellular and extracellular associated TGF-β in the skin of the patients with systemic sclerosis (sleroderma) and primary Raynaud's phenomenon. Clin Immunol Immunopathol 1993; 68:340-9.
25. Higley H, Persichitte K, Chu S, Waegell W, Vancheeswaran R, Black C. Immunocytochemical localization and serologic detection of transforming growth factor beta 1: Association with type I procollagen and inflammatory cell markers in diffuse and limited systemic sclerosis, morphea, and Raynaud's phenomenon. Arthritis Rheum 1994; 37:278-88.
26. Gharace-Kermani M, Denholm EM, Phan SH. Costimulation of fibroblast collagen and transforming growth factor β1 gene expression by monocyte chemoattractant protein-1 via specific receptors. J Biol Chem 1996; 271:17779-84.